Skip to content

Older Adults' Attitudes Towards Stopping Aspirin

Older Adults' Attitudes Towards Stopping Aspirin

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07305376
Enrollment
2819
Registered
2025-12-26
Start date
2025-11-10
Completion date
2025-11-30
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Overuse

Brief summary

This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.

Interventions

OTHERAdditional harm information

Participants received additional information about the harm of continuing aspirin.

OTHERLess information

Participants will receive less information about the risk of harms of continuing aspirin.

Sponsors

University of Michigan
Lead SponsorOTHER
University of Sydney
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Reside in Australia or the United States * 65 years and older

Exclusion criteria

* Unable to read survey written in English

Design outcomes

Primary

MeasureTime frame
"How safe do you think it would be to continue taking aspirin?" measured on a 6-point Likert scaleDay 1
"How helpful do you think it would be to continue taking aspirin?" measured on a 6-point Likert scaleDay 1

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSarah Vordenberg, PharmD, MPH

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026